Citation: | FU Xiaoting, CHEN Minhui, YAN Fei, HANG Taijun. Identification of the related substances of tacrolimus by LC-MS[J]. Journal of China Pharmaceutical University, 2022, 53(5): 563-576. DOI: 10.11665/j.issn.1000-5048.20220507 |
[1] |
. Curr Drug Metab,2018,19(4):342-350.
|
[2] |
Kropeit D,von Richter O,Stobernack HP,et al. Pharmacokinetics and safety of letermovir coadministered with cyclosporine A or tacrolimus in healthy subjects[J]. Clin Pharmacol Drug Dev,2018,7(1):9-21.
|
[3] |
Wang LP,Ma KF,Yao Y,et al. Carcinogenicity risk associated with tacrolimus use in kidney transplant recipients:a systematic review and meta-analysis[J]. Transl Androl Urol,2022,11(3):358-366.
|
[4] |
Mok CC. Calcineurin inhibitors in systemic lupus erythematosus[J]. Best Pract Res Clin Rheumatol,2017,31(3):429-438.
|
[5] |
Tian JR,Luo YE,Wu HJ,et al. Risk of adverse events from different drugs for SLE:a systematic review and network meta-analysis[J]. Lupus Sci Med,2018,5(1):
|
[6] |
Li GQ,Zeng S. Determination of related substances of tacrolimus by HPLC with gradient elution[J]. Chin Pharm J(中国药学杂志),2008,43(7):551-553,558.
|
[7] |
Chen Y. HPLC determination of tacrolimus and its related substances[J]. Chin J Pharm Anal(药物分析杂志),2008,28(2):309-313.
|
[8] |
Liu HP,Ma P,Li PF,etal.Domestic and imported tacrolimus capsules in healthy human bodyPharmacokinetics and bioequivalence[J].Chin J Pharm Clin Rem(中国药物与临床),2008,8(1):65-66.
|
[9] |
Mohanty L,Bhushan S,Rüttger B. Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects:a randomized,two-period crossover trial[J]. Int J Clin Pharmacol Ther,2020,58(3):183-193.
|
[10] |
Lho?st G,Hertsens R,Verbeeck RK,et al. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry[J]. J Mass Spectrom,2001,36(8):889-901.
|
[11] |
TLC Tacrolimus related substance reference materials[EB/OL]. (
|
[12] |
Chen YX,Xie Y,Wen YM,et al. Study on the fragmentation pathway of tacrolimus and ascomycin by ESI MSn under negative mode[J]. Chin J Antibiot(中国抗生素杂志),2011,36(1):25-29.
|
[13] |
Ni YL,Han X,Song M,et al. Identification of the related substances of cyclosporin A by LC-MS techniques[J]. J China Pharm Univ(中国药科大学学报),2019,50(4):423-437.
|
[1] | NING Manru, XU Kehui, HANG Taijun, SONG Min. Separation and identification of folic acid and its related substances by liquid chromatography-mass spectrometry[J]. Journal of China Pharmaceutical University, 2025, 56(1): 56-64. DOI: 10.11665/j.issn.1000-5048.2024052201 |
[2] | XIA Ying, LONG Jiayi, DAI Haoran, SHEN Mengyuan, GUO Hongli, HU Yahui, CHEN Feng. Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients[J]. Journal of China Pharmaceutical University, 2021, 52(6): 719-724. DOI: 10.11665/j.issn.1000-5048.20210610 |
[3] | XIA Ying, GUO Hongli, HU Yahui, CHEN Feng. Therapeutic drug monitoring for monoclonal antibody:progress in the application of LC-MS/MS technique[J]. Journal of China Pharmaceutical University, 2021, 52(1): 122-128. DOI: 10.11665/j.issn.1000-5048.20210117 |
[4] | NI Yueling, HAN Xing, SONG Min, HANG Taijun. Identification of the related substances of cyclosporin A by LC-MS techniques[J]. Journal of China Pharmaceutical University, 2019, 50(4): 423-437. DOI: 10.11665/j.issn.1000-5048.20190407 |
[5] | LIANG Fangmei, NI Yueling, WANG Lu, HANG Taijun, SONG Min. Structural identification of the related substances of fusidic acid by LC-MS[J]. Journal of China Pharmaceutical University, 2018, 49(3): 322-332. DOI: 10.11665/j.issn.1000-5048.20180311 |
[6] | LIU Chaoyi, ZHANG Ge, HANG Taijun, WANG Lei, ZHANG Xiaofei, SONG Min. Identification of related substances in rivaroxaban by LC-MS[J]. Journal of China Pharmaceutical University, 2015, 46(4): 450-457. DOI: 10.11665/j.issn.1000-5048.20150411 |
[7] | ZHANG Lu, QIANG Shuping, ZHANG Yunjing, WANG Lei, ZHANG Xiaofei, HANG Taijun. Preliminary identification of the related substances in cisatracurium besylate for injection by LC-MS[J]. Journal of China Pharmaceutical University, 2013, 44(1): 65-72. DOI: 10.11665/j.issn.1000-5048.20130111 |
[8] | KONG Xing-xin, SHEN Wen-bin, WANG Li-yun, SHI Jin-fang, DI Bin, ZHANG Tao. Identification of the related substances in cefmetazole sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2012, 43(2): 170-176. |
[9] | QIN Fang, DING Ya, HANG Tai-jun, SONG Min. Identification of the related substances in faropenem sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2011, 42(4): 342-347. |
[10] | TIAN Yuan, FENG Shu-dan, HUANG Mei-hua, ZHANG Zun-jian. LC-MS/MS determination of glucocorticoids illegally added into cosmetics[J]. Journal of China Pharmaceutical University, 2011, 42(1): 53-57. |
1. |
王圆超,赵辉,王月,谷岩翡,高月麒,李晓露. 他克莫司的分离提纯研究. 中国抗生素杂志. 2024(02): 175-180 .
![]() | |
2. |
楚士颖,周玉松,张怡铭,唐雨晴,朱思宇,程文播. 液相色谱-串联质谱法同时测定血清中四种免疫抑制剂的药物浓度. 中国当代医药. 2024(09): 7-10+15 .
![]() |